Non-Opioid Strategies That Works for Pain Management

Find out the best pain management combined with non-opioid strategies to take control of your health and ease your pain effectively.

Integrative Pain Management: My Multimodal Approach Beyond Opioids — Combining Chiropractic Care and PRP Therapy

I am Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. Over decades of clinical practice in chiropractic and functional medicine, I have refined an evidence-based, integrative pathway for assessing and treating chronic pain, neuropathic pain, persistent post-surgical and post-traumatic pain, and myofascial pain. In this educational post, I guide you through the modern framework of total pain using the biopsychosocial model; I differentiate nociceptive versus neuropathic pain and acute versus chronic pain; and I present targeted strategies for persistent post-surgical and post-traumatic neuropathic pain syndromes as well as common peripheral neuropathy patterns. I explain why multimodal pharmacology (SNRIs, gabapentinoids, sodium-channel modulators, topical agents, short-course steroids), integrative chiropractic care, and regenerative PRP (platelet-rich plasma) therapy work synergistically to improve function, reduce central sensitization, promote tissue healing, and protect long-term health.

Crucially, this care occurs within a multidisciplinary clinic in El Paso, Texas: Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic), where I collaborate with Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine, NPI #1164426749, Texas MD License #J2933). With over 40 years of experience as an internist, Dr. Cardenas serves as our Medical Director and Collaborative Physician, providing medical direction common to modern integrative and injury clinics. Together, we blend internal medicine oversight, chiropractic precision, functional medicine, rehabilitation, regenerative therapies including ultrasound-guided PRP injections, and personal injury services to deliver safe, comprehensive, and personalized care. Clinical observations from my practice are available at Chiropracticscientist.com and on my professional LinkedIn profile.

—

Our Multidisciplinary Model: Internal Medicine Direction Meets Integrative Chiropractic Care and Regenerative PRP Therapy

At Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, our multidisciplinary model is the backbone of safe, effective pain management. I serve as a chiropractor, advanced practice nurse, and functional medicine practitioner; Dr. Maria Guadalupe Cardenas, MD, an internist with over 40 years of experience, provides medical direction and collaborative oversight. This setup reflects the standard in integrative and injury care clinics: an MD guides diagnostics and pharmacology, while a chiropractor delivers rehabilitative, biomechanical, and neuromuscular therapies, and our team incorporates regenerative interventions, such as ultrasound-guided PRP injections, to support tissue repair.

What our integrated team provides:

• Medical diagnostics and oversight (labs, imaging, pharmacology, contraindication screening)
• Integrative chiropractic care (spinal and regional joint assessment, adjustments, neuromuscular rehabilitation)
• Regenerative PRP therapy (autologous platelet-rich plasma prepared and delivered under ultrasound guidance to promote healing in soft tissues, joints, and areas of chronic irritation)
• Functional medicine strategies (metabolic, inflammatory, nutritional drivers; lifestyle optimization)
• Rehabilitation programs (corrective exercise, motor control, graded exposure)
• Personal injury services (documentation, impairment ratings, functional capacity tracking)
• Care coordination (neurology, pain management, orthopedics, and other specialists as needed)

This coordinated framework allows us to titrate medications safely, align manual therapies, deliver regenerative injections, and address systemic and biomechanical contributors to pain, optimizing outcomes while preventing complications.

—

Rethinking Pain: Understanding Total Pain Through the Biopsychosocial Lens

Pain, as defined by the International Association for the Study of Pain, is an unpleasant sensory and emotional experience—a direct reminder that the mind and body co-create how pain is perceived and tolerated. In chronic and persistent pain conditions, pain is often “total pain,” a convergence of physical pathology with psychological distress, social stressors, and existential concerns. Tissue injury, surgical trauma, repetitive strain, or degenerative changes are physical triggers; yet fear, loss of function, sleep disruption, or mood changes can amplify the pain experience.

Key elements of comprehensive assessment:

• Screen for distress (depression, anxiety, catastrophizing, social disruptions, sleep disturbance) to identify amplifiers of pain and refer to appropriate mental health or support resources as necessary.
• Listen for disproportionate pain relative to objective findings—this is a signal to explore underlying mood, autonomic, or lifestyle drivers.
• Engage a multidisciplinary team—psychology for mental health, social work or care coordination for resources, internal medicine for pharmacology and safety, chiropractic for biomechanical and neuromodulatory input, and regenerative approaches like PRP for tissue-level healing.

Why this matters: a full assessment allows us to treat the person, not just the symptom, reducing barriers that derail pain control and improving adherence to the plan.

References (selected): Raja, S. N., et al. (2020). The revised International Association for the Study of Pain definition of pain. Pain.

—

Prevalence and Persistence: Why Comprehensive Pain Management Must Address Chronic and Post-Injury States

Chronic pain remains widespread. Approximately 21% of U.S. adults experience chronic pain, with a significant subset reporting high-impact chronic pain that substantially limits daily activities. Pain frequently persists after injuries or surgeries: studies show that 10–50% of patients develop persistent post-surgical or post-traumatic pain lasting more than three months, with median rates around 20–30% at 6–12 months depending on the procedure or trauma.

Clinical reality: many patients arrive in clinic with ongoing pain and functional limitations long after the initial injury or procedure has “healed.” These cases demand a health-promotion focus—restoring mobility, reducing sensitization, supporting tissue repair with regenerative options like PRP, tapering unnecessary opioids where possible, and building resilience through education and integrative therapies.

—

Decoding Pain Mechanisms: Nociceptive vs. Neuropathic and Acute vs. Chronic

The mechanism and duration of pain guide therapy selection.

Nociceptive pain:

• Somatic pain: skin, muscles, bones, soft tissues; often sharp, throbbing, aching, well-localized (e.g., joint or myofascial sources).
• Visceral pain: internal organs; deep, gnawing, cramping, diffuse and harder to localize.

Neuropathic pain:

• Originates from lesions or disease of the somatosensory system; described as burning, tingling, electric shocks, numbness (e.g., peripheral neuropathy patterns or post-traumatic nerve irritation). These qualitative features signal the need for neuropathic agents, neuromodulatory strategies, and regenerative support.

Duration distinctions:

• Acute pain: short-term protective response (e.g., first 7–10 days post-injury or surgery); limited short-term role for certain medications when appropriate.
• Chronic pain: ?90 days persistence; the nervous system undergoes central sensitization—a maladaptive amplification of pain signals—making long-term opioids risky and often suboptimal. Here, non-opioid pharmacology, chiropractic neuromodulation, rehabilitation, and regenerative PRP become essential.

Rationale: precise classification means we match mechanism to treatment, leading to superior outcomes and fewer side effects.

References (selected): National Comprehensive Cancer Network Adult Cancer Pain guidelines (general principles adapted); Bouhassira et al. on DN4 (2005).

—

Integrative Chiropractic Care: Neuromodulation, Biomechanics, and Functional Gains

My role as a Doctor of Chiropractic is to deliver non-pharmacologic, hands-on therapies that complement medical management and regenerative interventions. For patients with chronic pain, post-injury recovery, or persistent post-surgical limitations, our chiropractic approach is gentle, targeted, and neurologically informed.

How chiropractic care fits:

• Managing somatic and myofascial pain: gentle spinal and extremity adjustments alleviate musculoskeletal pain, restore joint mobility, and reduce muscle guarding from inactivity or injury-related stress.
• Neuromodulation for neuropathic pain: adjustments deliver afferent sensory input that can modulate dorsal horn signaling—thereby functionally supporting “gate control” and reducing hypersensitivity.
• Functional improvement: by restoring mobility and motor control, patients remain active, better tolerate rehabilitation, and regain daily function—key outcomes in long-term recovery.

Safety is paramount: under Dr. Cardenas’s internal medicine oversight, we screen for contraindications (e.g., instability, acute fractures, or other red flags) and adapt techniques to protect vulnerable tissues. Clinical insights on ChiropracticScientist.com and LinkedIn detail how normalizing spinal kinematics reduces nociceptive input and central amplification, enhancing descending inhibitory control and synergizing with multimodal strategies including PRP.

Sources: Chiropracticscientist.com; Dr. Alex Jimenez on LinkedIn.

—

Challenging Pain Syndromes: Persistent Post-Surgical and Post-Traumatic Neuropathic Pain

Persistent post-surgical and post-traumatic neuropathic pain syndromes affect a meaningful percentage of patients after procedures or injuries involving peripheral nerves. Pain distribution follows the affected nerve territories and may include numbness, tingling, shooting, burning, or cold sensations. Risk factors include extent of trauma or surgery, nerve retraction or scarring, adjuvant factors, and psychosocial elements (depression, anxiety, catastrophizing) that increase risk and severity.

Early multimodal strategies (neuropathic agents initiated around the time of injury or surgery when appropriate, combined with rehabilitation) show promise in reducing incidence and severity in various post-traumatic and post-surgical contexts.

Why integrative care helps:

• Combining neuropathic pharmacology, targeted chiropractic neuromodulation, rehabilitation, and regenerative PRP therapy simultaneously addresses peripheral nerve irritation, central amplification, biomechanical overload, and tissue healing. PRP’s growth factors can support nerve and soft-tissue repair in selected cases, while chiropractic restores alignment and afferent input.

—

Peripheral Neuropathy and Neuropathic Pain: Mechanisms, Risks, and Multimodal Care

Neuropathic pain often presents in classic length-dependent (stocking-glove) patterns or focal distributions depending on the underlying driver. Patients report numbness, tingling, pins and needles, burning, or electric shocks. Common contributors include metabolic factors (e.g., diabetes), compressive or entrapment neuropathies, post-traumatic or post-surgical nerve irritation, inflammatory processes, and certain medication-related or idiopathic causes.

Clinical realities:

• Symptoms can limit function and quality of life; early multimodal intervention is key.
• Risk factors: older age, metabolic conditions, obesity/low activity, genetic predisposition, and lifestyle factors.

Why the multimodal approach:

• Neuropathic pain reflects injury to the somatosensory system and central sensitization. We combine SNRIs and gabapentinoids with chiropractic neuromodulation, exercise-based rehabilitation, and regenerative PRP (which may offer anti-inflammatory and tissue-supportive effects in selected neuropathic and mixed-pain presentations) to stabilize firing, improve descending inhibition, promote local healing, and restore function.

—

Regenerative PRP Therapy: Enhancing Pain Management and Tissue Repair

PRP (platelet-rich plasma) therapy is a cornerstone of our regenerative approach. We prepare autologous PRP from the patient’s own blood, concentrating platelets and growth factors, then deliver it under ultrasound guidance to targeted areas of chronic irritation, tendinopathy, joint degeneration, myofascial trigger points, or post-injury soft tissue.

How PRP supports pain management:

• Growth factors promote tissue repair, modulate inflammation, and support healing in tendons, ligaments, muscles, and joints—common sources or contributors to chronic and neuropathic pain.
• Evidence shows PRP can reduce pain and improve function in chronic tendinopathies, osteoarthritis-related pain, and select myofascial/trigger-point presentations, often with effects lasting months to years in responders.
• When combined with chiropractic care, PRP addresses the body’s natural healing environment, while adjustments restore biomechanics and neuromuscular control, creating synergistic, longer-lasting results.

At our clinic, PRP is integrated into comprehensive plans for patients who have not achieved adequate relief with conservative care alone or who seek to reduce reliance on medications. Post-injection soreness is typically transient; we provide clear aftercare and integrate it with rehabilitation to achieve optimal outcomes.

—

Myofascial Pain Syndrome: Physiology, Diagnosis, and Integrative Treatment (Including PRP Adjuncts)

Myofascial pain syndrome (MPS) is ubiquitous in chronic pain and personal injury cases—often accounting for 30–85% of musculoskeletal pain complaints. It features trigger points—hyper-irritable nodules within taut bands of muscle that reproduce familiar pain and can refer to distant regions.

Physiological underpinnings, risk factors, and diagnosis follow established Travell and Simons criteria (palpable taut bands, tender nodules, referred pain, local twitch response). In patients with complex pain histories, we exclude structural pathology with appropriate imaging before assigning pain solely to MPS.

Integrative treatment blueprint:

• Chiropractic care: spinal and regional joint adjustments to restore joint centration and reduce biomechanical overload; soft tissue release and instrument-assisted techniques to improve fascial glide; trigger point therapies (manual ischemic compression, dry needling when appropriate).
• Regenerative PRP: ultrasound-guided injections into persistent trigger points or affected muscle/fascia have shown promise in reducing pain and improving muscle function and elasticity in MPS.
• Rehabilitation: eccentric/isometric loading, motor control retraining, breath mechanics.
• Functional medicine: address nutrition, inflammation, sleep, and autonomic balance.
• Adjunct pharmacology: topical agents, careful NSAID use when appropriate, short steroid bursts under medical supervision when indicated.
• Education and pacing: pain neuroscience education, graded exposure, clear expectations.

Why it works: we reduce peripheral drivers, restore kinematics, support tissue healing with PRP, and dampen central sensitization—decreasing the need for higher medication doses and promoting durable functional recovery.

References (selected): Travell & Simons (1999); Shah et al. (2015).

—

Pharmacological Framework Beyond Opioids: Mechanism-Based, Multimodal Strategy

We emphasize multimodal pharmacology at lower doses to maximize analgesia and minimize side effects by targeting complementary mechanisms: reducing ectopic discharges, stabilizing synaptic transmission, dampening glial activation, and enhancing descending inhibition.

Core options (acetaminophen, NSAIDs/COX-2 inhibitors with appropriate caution, SNRIs, gabapentinoids, sodium-channel modulators, topical agents, short-course corticosteroids) remain valuable when carefully selected and monitored. Diagnostic support with tools such as the DN4 questionnaire (scores> 4 suggest neuropathic pain) adds objectivity. Titration best practices: start low and go slow, set clear endpoints, use regular follow-up.

References (selected): Moore et al. (2015) on antidepressants for chronic pain; Bouhassira et al. (2005) on DN4; general principles from pain management guidelines.

—

Mechanistic Synergy: How Chiropractic Care and PRP Enhance Pharmacologic Analgesia

Chiropractic interventions and PRP therapy produce mechanistic synergy with pain pharmacology:

• Normalizing joint kinematics reduces nociceptive input and improves effectiveness of SNRIs and gabapentinoids.
• Soft-tissue and trigger-point therapies (including PRP) alleviate peripheral sensitization and improve local perfusion and healing.
• Neuromuscular rehabilitation and regenerative support re-establish motor patterning and tissue integrity, often enabling lower pharmacologic doses and more sustainable outcomes.

Clinical observations show consistent functional gains when manual therapy and PRP are integrated with mechanism-based pharmacology, particularly in mixed and neuropathic pain presentations.

—

Safety Practices Under Internal Medicine Oversight

With Dr. Cardenas providing medical direction, we embed structured safety protocols:

• Renal dosing and monitoring for gabapentinoids; electrolyte surveillance for certain sodium-channel agents.
• LFT monitoring and vigilance for serotonergic effects with SNRIs.
• For PRP: sterile ultrasound-guided technique, screening for contraindications (active infection, bleeding disorders, etc.), and clear post-procedure instructions.
• Short-term steroid use with clear stop rules and prompt tapering when used.

Outcome: a medical-chiropractic-regenerative collaboration ensures that therapies are clinically justified, documented, and patient-specific, thereby reducing adverse events.

—

Education and Expectation-Setting: The Cornerstone of Adherence and Outcomes

I invest time in patient education. When patients understand the mechanism of each intervention (medication, adjustment, or PRP injection), realistic timelines for relief, the role of chiropractic and regenerative therapies in reducing pain inputs and supporting healing, and the importance of follow-up and lifestyle factors, they participate actively and experience better outcomes. Tools like the DN4 and clear expectation-setting sustain engagement even in complex pain profiles.

—

Conclusion: A Modern, Evidence-Based Pathway for Chronic, Neuropathic, and Myofascial Pain

By integrating internal medicine oversight from Dr. Maria G. Cardenas, MD, with chiropractic care, regenerative PRP therapy, functional medicine, and rehabilitation, we deliver a precise, mechanism-based strategy for chronic pain, neuropathic pain, persistent post-surgical and post-traumatic pain, and myofascial pain. We accurately classify pain, apply validated tools, thoughtfully titrate multimodal pharmacology, leverage neuromuscular and biomechanical corrections, and use PRP to support tissue repair and reduce inflammation at the source.

This approach is patient-centered, safety-forward, and deeply rooted in modern evidence. Our mission is to help patients not simply manage pain, but restore function, reduce reliance on long-term opioids where appropriate, and thrive—with better mobility, fewer side effects, and a durable return to the activities that matter.

—

References

• Raja, S. N., et al. (2020). The revised IASP definition of pain. Pain.
• Rikard, S. M., et al. (2023). Chronic Pain Among Adults — United States, 2019–2021. MMWR.
• Rosenberger, D. C., et al. (2022). Chronic post-surgical pain – update on incidence, risk factors… British Journal of Anesthesia.
• Moore, R. A., et al. (2015). Antidepressants for chronic pain in adults. Cochrane Database.
• Bouhassira, D., et al. (2005). The DN4 questionnaire… Journal of Pain.
• Travell, J. G., & Simons, D. G. (1999). Myofascial Pain and Dysfunction: The Trigger Point Manual.
• Shah, J. P., et al. (2015). Myofascial trigger points then and now. Journal of Pain.

SEO tags: chronic pain management, integrative chiropractic care, PRP therapy, regenerative pain management, ultrasound-guided PRP, neuropathic pain, myofascial pain syndrome, persistent post-surgical pain, post-traumatic pain, multimodal analgesia, duloxetine, gabapentin, pregabalin, central sensitization, DN4 questionnaire, biopsychosocial model of pain, internal medicine oversight, El Paso Texas, Injury Medical Clinic PA, Mission Plaza Injury Medical Clinic, Dr Alex Jimenez, Dr Maria Guadalupe Cardenas, functional medicine, rehabilitation, personal injury care, evidence-based pain protocols, post-injury pain, trigger point pain, tissue healing, non-opioid pain strategies